No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
TRML240621C20000
- 0.15
- 0.000.00%
15min DelayTrading May 30 10:38 ET
0.00High0.00Low
0.00Open0.15Pre Close0 Volume3 Open Interest20.00Strike Price0.00Turnover118.38%IV46.87%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.0974Delta0.0474Gamma91.47Leverage Ratio-0.0168Theta0.0006Rho8.91Eff Leverage0.0053Vega
Intraday
- 5D
- 1D
News
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients
Express News | Tourmaline Bio Inc: Topline Data Anticipated in First Half of 2025
Express News | Tourmaline Bio Initiates Clinical Development of Tour006 for Cardiovascular Diseases With First Patient Dosed in Phase 2 Tranquility Trial
Truist Financial Reaffirms Their Buy Rating on Tourmaline Bio (TRML)
Express News | HC Wainwright & Co. Reiterates Buy on Tourmaline Bio, Maintains $48 Price Target
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Tourmaline Bio (TRML)
Comments
Last two days have been phenomenal $NKGEN BIOTECH(NKGN.US$ $Apollomics(APLM.US$
Try to keep it going. Buying these for Monday.
$Leju Holdings(LEJU.US$
$Ryvyl(RVYL.US$
Still holding. But they are getting close to pulling back.
$Global Mofy Metaverse(GMM.US$
$Tourmaline Bio(TRML.US$
Try to keep it going. Buying these for Monday.
$Leju Holdings(LEJU.US$
$Ryvyl(RVYL.US$
Still holding. But they are getting close to pulling back.
$Global Mofy Metaverse(GMM.US$
$Tourmaline Bio(TRML.US$
8
6
$Tourmaline Bio(TRML.US$ Next resistance is at 27.00. Has a PT of 65.00 given yesterday.
2
2
Read more